showed a trendP < 0.05
Among the 10 platinum agent assays, 2 assays (Oxaliplatin 1, Cisplatin 1) showed a trend of higher AUCs in cell lines with BRCA alterations (unadjusted P < 0.05, adjusted P ≧ 0.05), while no assays showed lower AUCs.
Among the 10 platinum agent assays, 2 assays (Oxaliplatin 1, Cisplatin 1) showed a trend of higher AUCs in cell lines with BRCA alterations (unadjusted P < 0.05, adjusted P ≧ 0.05), while no assays showed lower AUCs.